B

Biogen

Develops therapies for neurological disorders

Financial Analyst Intern

Corporate Finance & FP&AConfirmed live in the last 24 hours
InternshipParis, FranceNo salary listedHybrid

About the Job

Requirements

  • A higher education qualification in finance, from a business school or university.
  • Advanced Excel skills.
  • Fluency in French and English.
  • Knowledge of auditing, management control or financial control, budget monitoring, and financial reporting.
  • Knowledge of general accounting and French accounting standards and US GAAP.
  • Ability to act as a business partner.
  • Analytical and synthesis skills.
  • Ability to manage urgency and priorities.
  • Project management and cross-functional management skills.
  • Ability to work in a team and with international colleagues.
  • Rigor, proactivity, respect for deadlines, and strong interpersonal skills.

Responsibilities

  • Assist the Management Controller with analysis, controls, internal audit, and financial reporting across all activities.
  • Ensure operations are consistent with strategy, resources are allocated and optimized, and return on investment is analyzed.
  • Prepare monthly reporting for Management and Corporate, including actual-versus-budget analyses of product sales, expenses, and headcount.
  • Participate in budget revisions and budget meetings with departments.
  • Optimize the quality of data available in the information system.
  • Assist the Management Controller in working with external and internal auditors.
  • Conduct internal audits to ensure compliance with Group directives and internal procedures.
  • Participate in monthly closings, including preparing accruals and allocating costs analytically.
  • Optimize Finance processes and procedures.

About the Company

Biogen

Develops therapies for neurological disorders

Biogen is a global biotechnology company focused on neuroscience. It discovers, develops, and delivers therapies for neurological disorders, such as multiple sclerosis and other neurodegenerative diseases. Its product process starts with research and development to identify potential drugs, followed by clinical testing and regulatory approval, ultimately leading to commercialization and patient treatment. Biogen differentiates itself through a long history (founded in 1978), a deep specialization in neuroscience, and an integrated pipeline that moves ideas from discovery to approved medicines, aiming to create value for shareholders while helping communities. The company’s goal is to advance therapies for neurological diseases to improve patients’ lives and generate sustainable value for stakeholders.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
1978

Recently Posted Jobs

Explore more opportunities at Biogen

See more jobs